- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Secondary Hyperparathyroidism Due to Renal Causes
Total 213 results
-
AmgenTerminatedHyperparathyroidism | Chronic Kidney Disease | Secondary Hyperparathyroidism | Hyperparathyroidism, Secondary | Kidney DiseaseUnited States, Belgium, Hungary, Spain, Australia, Germany, Poland, Mexico, Russian Federation, Slovakia
-
AmgenCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States, Italy, Belgium, Denmark, Switzerland, Canada, Turkey, Spain, Austria, Germany, Hungary, Greece, France, Poland, Russian Federation, Czechia, Latvia, Lithuania, New Zealand, Portugal, Sweden, Estonia
-
AbbVie (prior sponsor, Abbott)CompletedHemodialysis | Secondary HyperparathyroidismJapan
-
AbbottAbbott Japan Co.,LtdCompletedHemodialysis | Secondary HyperparathyroidismJapan
-
AbbottCompletedSecondary Hyperparathyroidism | Chronic Kidney FailureGreece
-
AbbVie (prior sponsor, Abbott)CompletedSecondary Hyperparathyroidism | Kidney InsufficiencyAustria, Germany
-
OPKO Health, Inc.CompletedChronic Kidney Disease | Secondary Hyperparathyroidism | Vitamin D InsufficiencyUnited States
-
Washington University School of MedicineAbbott; NorthShore University HealthSystem; Northwestern University Feinberg... and other collaboratorsCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
AbbottAbbott Japan Co.,LtdCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease on HemodialysisJapan
-
AmgenCompleted
-
AbbVie (prior sponsor, Abbott)CompletedSecondary Hyperparathyroidism | Chronic Kidney FailureGreece
-
AbbVie (prior sponsor, Abbott)North America Pediatric Renal Trials and Collaborative Studies (NAPRTCS)TerminatedEnd-Stage Renal Disease | Secondary HyperparathyroidismUnited States
-
AbbottCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease, Stage 5United States
-
AbbVie (prior sponsor, Abbott)CompletedEnd-Stage Renal Disease | Secondary Hyperparathyroidism
-
AbbottCompletedRenal Insufficiency, Chronic | Hemodialysis | Secondary Hyperparathyroidism | Hypercalcemia | Parathyroid HormonePeru
-
AbbVieRecruitingChronic Kidney Disease (CKD) | Secondary Hyperparathyroidism (SHPT)United States, Puerto Rico
-
AbbVie (prior sponsor, Abbott)CompletedChronic Kidney Disease | Secondary HyperparathyroidismGreece
-
University of VirginiaWithdrawnChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
Shanghai Hengrui Pharmaceutical Co., Ltd.RecruitingSecondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on HemodialysisChina
-
AbbVie (prior sponsor, Abbott)Assign Data Management and Biostatistics GmbHCompletedSecondary Hyperparathyroidism | Chronic Kidney Disease Stage V | Cardiac MorbidityAustria
-
Saint Petersburg State University, RussiaCompletedHypocalcemia | Secondary Hyperparathyroidism | Dialysis | Hypoparathyroidism | Chronic Kidney Disease-Mineral and Bone DisorderRussian Federation
-
University of Sao Paulo General HospitalUnknownChronic Kidney Disease | Secondary HyperparathyroidismBrazil
-
AbbVie (prior sponsor, Abbott)Pharma Consulting Group ABCompletedChronic Kidney Disease | Secondary HyperparathyroidismSweden
-
Salem Veterans Affairs Medical CenterAbbottCompletedChronic Kidney Disease | Secondary HyperparathyroidismUnited States
-
University of Roma La SapienzaCompletedEvaluation of iMmune Function in Post-surgical and AuToimmune HYpoparathyroidism (EMPATHY) (EMPATHY)Hypoparathyroidism | Hypoparathyroidism Postprocedural | Hypoparathyroidism Due to Impaired Parathormone SecretionItaly
-
Central Hospital, Nancy, FranceRecruitingRespiratory Compliance | ARDS Due to Disease Caused by SARS Co-V-2 | Sequels of COVIDFrance
-
Zealand University HospitalTerminatedVitamin D Deficiency | Chronic Kidney Disease | Secondary HyperparathyroidismDenmark
-
Chunling JiangNot yet recruitingSecondary Hyperparathyroidism | End Stage Renal Failure
-
University Hospital, SaarlandCompletedHyperparathyroidism, Secondary | RENAL INSUFFICIENCY, CHRONICGermany
-
AmgenRecruitingChronic Kidney Disease | Secondary HyperparathyroidismKorea, Republic of, United States, India, Singapore, Taiwan, Argentina, Malaysia, Russian Federation, Turkey, Ukraine
-
Chang Gung Memorial HospitalCompletedVirus Diseases | Disorder Related to Transplantation | Injury Due to Exposure to External Cause
-
AmgenTerminatedChronic Kidney Disease | Hyperparathyroidism, SecondaryUnited States, Belgium, Italy, Hungary, Czechia, France, Germany, Poland, Netherlands, Russian Federation, New Zealand, Mexico, Slovakia
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, Switzerland, Canada, Turkey, Spain, Australia, Austria, Israel, Czechia, Hungary, Poland, France, Russian Federation, Germany, Denmark, Greece, Latvia, Lithuania, Netherlands, New Zealand, Portugal, Sweden
-
Boryung Pharmaceutical Co., LtdRecruitingSecondary Hyperparathyroidism | Chronic Kidney Disease 5DKorea, Republic of
-
The University of Hong KongCompletedVascular Diseases | Secondary Hyperparathyroidism | Kidney FailureHong Kong
-
Deltanoid PharmaceuticalsCompletedKidney Failure, Chronic | Hyperparathyroidism, SecondaryUnited States
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End Stage Kidney DiseaseUnited States, Bulgaria, Portugal, Spain, Serbia, Poland
-
AmgenCompletedCardiovascular Disease | Hyperparathyroidism | End Stage Renal Disease | Chronic Kidney Disease | Secondary Hyperparathyroidism | Chronic Renal Failure | Coronary Artery Calcification | Vascular Calcification | Kidney Disease | Calcification | Nephrology
-
University of California, Los AngelesLoma Linda UniversityCompletedSecondary HyperparathyroidismUnited States
-
Kepler University HospitalCompletedARDS Due to Disease Caused by SARS Co-V-2Austria
-
The First Hospital of Jilin UniversityCompletedARDS Due to Disease Caused by SARS Co-V-2China
-
Per IvarsenTerminatedChronic Kidney Disease | Secondary Hyperparathyroidism | Left Ventricular HypertrophyDenmark
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Austria, Czechia, Hungary, France, Israel, Poland, Australia, Russian Federation
-
Pathalys PharmaLaunch TherapeuticsRecruitingSecondary Hyperparathyroidism | End-stage Kidney Disease (ESKD)United States, Bulgaria, Spain, Portugal, Poland, Serbia
-
Azienda Ospedaliera Sant'AnnaAmgenUnknownHyperparathyroidism, SecondaryItaly
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Canada, France, Australia, Israel, Czechia, Hungary, Netherlands, Spain, Poland, Russian Federation, Italy, Sweden, Germany
-
AmgenCompletedHyperparathyroidism, SecondaryUnited States, Belgium, Italy, United Kingdom, Canada, Germany, Spain, Australia, Austria, Israel, Czechia, Hungary, Netherlands, Poland, France, Russian Federation, Sweden
-
Duke UniversityGenzyme, a Sanofi CompanyCompletedKidney Failure, Chronic | Hyperparathyroidism, SecondaryUnited States
-
Iain BressendorffNot yet recruitingSecondary Hyperparathyroidism | End-stage Kidney Disease